Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07346027 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Food Effect on Single-Dose Bioavailability of F-02-2-Na in Healthy Adult Subjects

StatusActive, Not Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 30, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status changed: Not Yet Recruiting → Active, Not Recruiting
    • Start date changed from estimate of Jul 1, 2026 to Jun 25, 2026
    • Site contact updated
    v3
  2. Start date: Feb 1, 2026 to Jul 1, 2026
    • Primary completion pushed from Apr 1, 2026 to Aug 1, 2026
    • Study completion pushed from Jun 1, 2026 to Sep 1, 2026
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is to evaluate the impact of food on the pharmacokinetics of F-02-2-Na in healthy adult subjects by observing the changes in the drug's pharmacokinetic profile-particularly in its absorption process-before and after food intake.
Trial Details
NCT Number NCT07346027
Lead Sponsor Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd.
Collaborators: Xiangbei Welman Pharmaceutical Co., Ltd, Guangzhou Xin-Chuangyi Biopharmaceutical Co., Ltd.
Conditions
(from sponsor)		 Hyperuricemia With or Without Gout
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov